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ABSTRACT
Background: Molecular and cellular mechanisms of neuropeptide-Y (NPY)-
mediated gender-difference in blood pressure (BP) regulation are largely unknown.
Methods: Baroreceptor sensitivity (BRS) was evaluated by measuring the response 
of BP to phenylephrine/nitroprusside. Serum NPY concentration was determined using 
ELISA. The mRNA and protein expression of NPY receptors were assessed in tissue 
and single-cell by RT-PCR, immunoblot, and immunohistochemistry. NPY was injected 
into the nodose while arterial pressure was monitored. Electrophysiological recordings 
were performed on nodose neurons from rats by patch-clamp technique.
Results: The BRS was higher in female than male and ovariectomized rats, 
while serum NPY concentration was similar among groups. The sex-difference was 
detected in Y1R, not Y2R protein expression, however, both were upregulated upon 
ovariectomy and canceled by estrogen replacement. Immunostaining confirmed 
Y1R and Y2R expression in myelinated and unmyelinated afferents. Single-cell PCR 
demonstrated that Y1R expression/distribution was identical between A- and C-types, 
whereas, expressed level of Y2R was ~15 and ~7 folds higher in Ah- and C-types than 
A-types despite similar distribution. Activation of Y1R in nodose elevated BP, while 
activation of Y2R did the opposite. Activation of Y1R did not alter action potential 
duration (APD) of A-types, but activation of Y2R- and Y1R/Y2R in Ah- and C-types 
frequency-dependently prolonged APD. N-type ICa was reduced in A-, Ah- and C-types 
when either Y1R, Y2R, or both were activated. The sex-difference in Y1R expression 
was also observed in NTS.
Conclusions: Sex- and afferent-specific expression of Neuropeptide-Y receptors 
in baroreflex afferent pathway may contribute to sexual-dimorphic neurocontrol of 
BP regulation.
INTRODUCTION
The pressor responses induced by neuropeptide Y 
(NPY) are greater in males compared with age-matched 
females [1] and the underlying molecular and cellular 
mechanisms are complex and largely unknown. Although 
no difference in serum concentration of NPY was found 
between genders, it could be elevated in both hypertensive 
men and women [2], suggesting at least that NPY itself 
would not be responsible for gender-related difference 
in blood pressure (BP) under physiological condition and 
the sex-differential expression of NPY receptors would be 
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highly expected in either peripheral or central site of BP 
regulation. Early studies have demonstrated that activation 
of type-I NPY receptor (Y1R) leads to a vasodepressor 
response [3, 4], while type-II NPY receptor (Y2R) activation 
induces vasopressor action in nucleus tractus solitarii 
(NTS) [4, 5], indicating that Y1R and Y2R activations 
often mediate an opposite pressor response. Several lines 
of evidence also imply the central mechanisms of NPY 
in BP regulation and potentially differential role of its 
receptor activation at different level of baroreflex afferent 
pathway, such as nodose ganglion (NG) and NTS. Firstly, 
significant effects of gender on the central actions of NPY on 
vasopressin and BP have been reported [6]; secondly, Y2R 
mRNA expression is dramatically increased in the NTS at 
hypertensive condition, whereas it is decreased in the NG 
under the same experimental condition [7], suggesting 
that NPY and its receptors participate in the BP regulation 
under both physiological and hypertensive condition via 
modulating baroreflex afferent function. Recent results 
have indicated that naturally occurring genetic variation 
at the Y1R locus has implications for heritable autonomic 
control of the circulation and hypertension, suggesting novel 
pathophysiological links among the Y1R locus, autonomic 
activity, and BP [8]. Y2R expression is upregulated in 
spontaneously hypertensive rats [9] and endogenous 
expression of Y2R is also documented in neuroendocrine 
cells and neuroendocrine tissues including the brainstem of 
a rodent model of hypertension [10].
Collectively, all published records indicate that NPY 
plays a pivotal role in BP regulation and development of 
hypertension through either peripheral or central pathway 
with gender-specific manner. However, there is no published 
record showing the sex-specific expression and distribution 
of Y1R and Y2R in baroreflex afferent pathway including NG 
and NTS under normal or hypertensive condition. Moreover, 
a low-threshold and sex-specific distribution of myelinated 
Ah-type baroreceptor neurons (BRNs) housed in NG and 
NTS has been identified [11–14]. The neuroexcitability of 
this subpopulation depends upon the presence of estrogen 
(17β-E2) [15–17] and is regulated by neurotransmitter [18], 
which may impact on the sexual dimorphism of baroreflex 
afferent function and neurocontrol of circulation [19]. 
Therefore, this study aims to explore sex- and afferent-
specific expression and distribution of Y1R and Y2R in 
NG and NTS at tissue and single-cell level, the effect of 
direct injection of Y1R or Y2R agonist into NG on the mean 
arterial pressure (MAP), and the ion channel mechanism of 
neuroexcitation induced by Y1R and Y2R activation.
RESULTS
Estrogen-dependent changes in baroreceptor 
sensitivity
To explore whether the depressor reflex modulation 
of blood pressure is female hormone-dependent, the 
baroreceptor sensitivity (BRS) was tested in adult males, 
age-matched females, as well as ovariectomized (OVX) 
female rats by measuring the mean arterial pressure 
(MAP) in the presence of phenylephrine (PE) or sodium 
nitroprusside (SNP) (2, 5, and 10 μg/kg; Figure 1A & 1B). 
Meanwhile, electrocardiogram (ECG) was monitored 
accordingly (Figure 1C & 1D). The results showed that 
the values of ∆HR/∆MABP, an index of BRS, were dose-
dependently increased in females than that in males, and 
reversed completely back to the level of males in the OVX 
rats (Figure 1E & 1F). This observation suggests that sex 
hormones may affect the function of catecholamines. The 
neuropeptide-Y (NPY), as a neurotransmitter and potent 
vasoconstrictor, influences sympathetic activation together 
with others including norepinephrine or angiotensin-
II [20]. In this regard, serum concentration of NPY was 
detected by ELISA, and no significant difference was 
observed between males and age-matched females (276.5 
± 144.9 vs. 266.4 ± 125.3 pg/ml, P > 0.05, n = 10). In 
addition, surgical removing of the ovaries did not affect 
serum NPY content (279.5 ± 98.6 pg/ml vs. either males 
or females, n = 8). These data suggested that serum 
NPY itself may not be the causal factor for the different 
baroreflex afferent function of males and female.
Sex-specific and/or -estrogen (17β-E2)-dependent 
expression of Y
1
R and Y2R in nodose ganglia
We then tested if there is any difference in the 
expression and distribution of NPY receptor between 
males and females. The protein expression of Y1R and 
Y2R was assessed in nodose ganglia (NG). The results 
showed that Y1R expression was lower (P < 0.01) in 
females compared with age-matched males, which was 
slightly but not significantly upregulated by ovariectomy 
(P = 0.116 vs. female). Nevertheless, Y1R was remarkably 
down-regulated by 17β-E2 treatment (P < 0.01 or P < 
0.05 vs. male or OVX) (Figure 2A and 2C). Notably, the 
expression of Y2R was dramatically enhanced by OVX 
(P < 0.05 vs. either male or female) and reversed (P < 
0.05 vs. OVX) by 17β-E2 treatment (Figure 2B and 2D) 
even though the expression level was identical between 
male and female rats. These observations suggest that 
the protein expression of both Y1R and Y2R are in a sex-
specific or estrogen-dependent manner in the NG.
Immunohistochemical analysis of Y
1
R and Y2R 
at tissue of nodose ganglia
To further confirm the expression of NPY receptors 
in nodose ganglion, the immunohistochemical staining 
was carried out. Both Y1R (Figure 3) and Y2R (Figure 
4) were detected in the cell-membrane and cytoplasm 
of myelinated afferents (HCN1-positive), whereas they 
were only detected in the cell-membrane of unmyelinated 
afferents (HCN1-nagetive, indicated as white arrowheads). 
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Figure 1: Effect on baroreflex sensitivity of gender difference during vasoactive drugs application. Femoral artery 
catheterization was applied to measure the change of MAP and venous cannula was used for administration of PE and SNP. A-B. The 
representative recordings of MAP collected from male (M; n = 7), female (F; n = 7), and ovariectomized (OVX; n = 4) rats in the presence 
of 2, 5, and 10 μg/kg of PE and SNP, respectively. C-D. The representative recordings of the heart rate (HR) along with the blood pressure 
(BP) changes; E-F. The summarized changes of BRS (∆HR/ΔMABP, bpm/mmHg) when treated with PE and SNP at different concentration 
in each group. The averaged data were expressed as means ± SD. *P < 0.05 and **P < 0.01 vs. Male group; #P < 0.05 and ##P < 0.01 vs. 
Female group. Scale bars were applied for all recordings.
Figure 2: Gender difference in protein expression of Y
1
R and Y2R in Nodose Ganglia. Protein was accessed in nodose ganglia 
of adult male (M), aged-matched female (F), ovariectomized (OVX) female rats and OVX administrated 17β-estradiol (17β-E2). A and B. 
Protein bands for Y1R and Y2R, respectively; C and D. Averaged data of relative expression profiles for Y1R and Y2R. The averaged data 
were presented as mean ± SD. n = 4 duplicated tests in which the tissue was collected from 10 rats of each group. *P < 0.05 and **P < 0.01 
vs. male, #P < 0.05 vs. OVX.
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Figure 3: Immunohistochemical staining for Y
1
R. The Y1R staining was performed in nodose ganglia from male (M, top), female 
(F, central), and ovariectomized (O, bottom) rats. The nucleus, hyperpolarization-activated channel specifically expressed on myelinated 
afferents (HCN1-positive), and Y1R were labeled by the antibodies against DAPI (blue), HCN1 (red), and Y1R (green). Arrowheads: 
indicate the neurons with unmyelinated afferents (HCN1-negative). The scale bar: 50 μm.
Figure 4: Immunohistochemical staining for Y2R. The Y2R staining was performed in nodose ganglia from male (M, top), female 
(F, central), and ovariectomized (O, bottom) rats. The nucleus, hyperpolarization-activated channel specifically expressed on myelinated 
afferents (HCN1-positive), and Y2R were labeled by the antibodies against DAPI (blue), HCN1 (red), and Y2R (green). Arrowheads: 
indicate the neurons with unmyelinated afferents (HCN1-negative). The scale bar: 50 μm.
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Quantification analysis (Supplementary Table S1) showed 
that, for Y1R/HCN1-positive, the fluorescent intensity was 
lower in female (P < 0.05 vs. male), which was further 
downregulated by OVX (P < 0.01 vs. female). There was 
no difference between males and age-matched females in 
Y2R/HCN1-positive, OVX dramatically upregulated Y2R 
level (P < 0.01 vs. female). In the case of HCN1-negative 
populations, the difference in fluorescent intensity for Y1R 
was not established among groups. However, the intensity 
for Y2R of females was higher (P < 0.05 vs. male) and 
completely reversed by OVX (P <0.01 vs. female). Even 
though the averaged results of fluorescent analysis do 
not completely match with molecular observations, the 
difference might be explained by the YR whole tissue 
detection in molecular analysis and the afferent-specific 
quantification in fluorescence. The YR expression in 
cells other than neurons such as the satellite cells around 
the neurons (as indicated by the pink area of merged 
images from Figure 3 and 4) in the tissue of NG may also 
significantly influence the final analysis.
Afferent-specific distribution of Y
1
R and Y2R in 
identified single BRNs from female rats
To determine the afferent-specific expression, 
single-cell RT-PCR was employed in identified single 
BRNs. The data (Figure 5A) showed that Y1R mRNA 
equally expressed and distributed (5/23 or 5/25) in 
A- and C-types, whereas very low expression level of 
Y1R was found in only 1 of 22 tested Ah-type BRNs 
(1/22, Figure 5A & bottom tab.), indicating almost no 
Y1R expression in Ah-types. However, Ah- and C-types 
BRNs expressed more than 15 and 7 folds (P < 0.05 vs. 
A-type) of Y2R (Figure 5B), respectively, even though 
the distribution in the number of positive detections 
was identical among A- (n = 7/23, 30.4%), Ah- (n = 
7/22, 31.8%), and C-types (10/25, 40%), suggesting 
a predominant role of Y2R in the function of Ah- and 
C-type BRNs (Figure 5 bottom tab.).
Y
1
R and Y2R activation-mediated changes in 
blood pressure by nodose ganglion injection
We then tested if Y1R and Y2R activation may 
produce opposite effects in BP regulation. The changes 
in mean arterial pressure (MAP) were investigated when 
NPY and selective agonists of Y1R, Pro-34 and Y2R, 
NPY13-36 were directly injected into NG (Figure 6). The 
results showed that both saline and 5 μg of NPY placed 
right on the surface of NG did not induce significant 
changes in BP (Figure 6A top and bottom). However, in 
male rats, 5 μg NPY and Pro-34 elevated BP dramatically 
(Figure 6B and 6C, top; P < 0.01 vs. control), whereas 5 
μg NPY-13-36 decreased BP (Figure 6D, top; P < 0.01 vs. 
control). Most importantly, the averaged data (Figure 6E) 
showed that Y1R-mediated BP elevations were stronger 
(Figure 6B & 6C, bottom tab., P < 0.01) compared with 
females with either NPY or Pro-34, suggesting Y1R 
activation-mediated BP upregulation at the level of NG. 
Intriguingly, the sex-difference in Y2R-mediated reduction 
of BP was not conformed and the effect of Y1R was much 
stronger than that of Y2R, suggesting that Y1R and Y2R 
activation play an opposite action in BP regulation at the 
1st-order neurotransmission of baroreflex afferent pathway, 
and NPY-mediated upregulation of BP by Y1R stimulation 




R or Y2R-mediated similar down-regulation of 
neuromodulation in myelinated A-type BRNs by 
inhibition of presynaptic Ca2+ channel
Upon the expression profile for Y1R in A-type 
BRNs, the effect of Y1R activation on action potential 
(AP) trajectory and N-type calcium currents (ICa) was 
investigated. Firstly, Y1R activation by Pro34 (100 
nM), Y1R selective agonist, showed no effects on AP 
waveshape and discharge profiles (Figure 7A-7C) but 
significantly reduced current density of ICa with equal 
efficacy of 300 nM ω-CTX. The current was completely 
blocked by BIBP3226 (300 nM), a Y1R selective 
antagonist and PTX 100 nM, the blocker for G-protein 
coupled receptor, respectively (Figure 7D-7G). Even 
though AP discharge was not changed in the presence 
of Pro34, Y1R activation-mediated reduction in current 
density of ICa may still change the neurotransmission 
in NTS due perhaps to the similar membrane structure 
between soma and its pre-synapse [21]. Similar results 
were also observed by Y2R activation in separate set of 
A-type BRNs under the same experimental condition 
(Data not shown). This phenomenon may attribute 
to lacking of the co-localization between KCa1.1 and 
N-type Ca2+ channels in myelinated A-type cells even 
though the expression of theses channels could be 
identified.
Y2R-mediated peripheral and integrations in 
sex-specific and low-threshold myelinated Ah-
type BRNs by presynaptic BK-KCa inactivation
Compared with A-types, a presumed leading role 
of Y2R in sexual dimorphism in BRx afferent function 
is expected considering its extremely higher expression 
in low-threshold and sex-specific myelinated Ah-type 
BRNs (Figure 5). In electrophysiological identified 
Ah-types (Figure 7A-7B), Y2R activation by NPY13-
36 (100 nM), a selective Y2R agonist, markedly 
prolonged AP duration (APD50) and slowed the maximal 
downstroke velocity (DVMAX) with increase in AP firing 
frequency (APFF) (Figure 8A-8F), notably broadened 
the frequency-dependent APD (Figure 8G-8I) and 
inhibited N-type ICa (Figure 8J-8M). These data imply 
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that the increased APD may allow more presynaptic Ca2+ 
influx and lead to more neurotransmitter release. This 
hypothesis seems reasonable, but Y2R activation caused 
ICa inhibition may also directly reduce the Ca
2+ influx at 
presynaptic membrane leading to an opposite action on 
neurotransmission. Therefore, additional investigations 
would definitely be necessary.
Y
1
R- and Y2R-mediated similar neuromodulation 
in unmyelinated baroreceptor afferents
In electrophysiological identified unmyelinated 
C-type BRNs, Y1R (Figure 9A-9C) and Y2R (Figure 9D-
9F) activation caused a similar APD50 prolongation and 
total inward current reduction as revealed by displacement 
current of phase plots with the decrease in the current 
density of ICa. In the presence of Pro34 and NPY16-36, 
the APFF was increased with an activity-dependent AP 
broadening. (Supplementary Table S2).
Sexual- and estrogen (17β-E2)-dependent 
expression of Y
1
R, rather than Y2R in NTS
The NTS is the center converged visceral afferent 
inputs from Vagus and aortic depressor nerve (ADN) 
relayed at the NG. The clarification of the expression and 
distribution of Y1R and Y2R in NTS would be critical for 
fully understanding of NPY-mediated sexual dimorphism 
in neurocontrol of circulation. To answer this question, 
the tissue of NTS were collected from adult male, age-
matched female, and OVX rats for the immunoblot 
study. The data (Figure 10) indicated that the expression 
of Y1R, rather than Y2R is sex-specific and estrogen-
dependent. Y1R expression in females was 161.7% (P 
< 0.05) compared with male group, and was completely 
downregulated in OVX to the equivalent level to males 
(Figure 10C). The mRNA expressions of Y1R and Y2R 
were also tested and identical expression pattern was 
observed (data not shown).
Figure 5: Cell-specific expression and distribution of mRNA of Y
1
R and Y2R in identified single BRNs from adult 
female rats. The action potential (AP) was collected under the current-clamp mode of whole-cell configuration and the afferent fiber 
types of BRNs was identified by standard electrophysiological validation, which was then collected for single-cell RT-PCR. A. Relative 
mRNA expression of Y1R; B. Relative mRNA expression of Y2R; n = 22-25. *P < 0.05 vs. A-type BRNs. The bottom table: the percentage 
distribution of Y1R and Y2R in each category neurons.
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DISCUSSION
The major contribution of the current investigation is 
to demonstrate for the first time that sex- and afferent-specific 
expression and distribution of Y1R and Y2R are observed in 
baroreflex afferent pathway including NG and NTS by the 
use of immunoblotting and immunohistochemistry, as well 
as single-cell RT-PCR technique in identified baroreceptor 
neurons. Additionally, activation of Y1R and Y2R mediate 
differential neuroexcitation and Ca2+ channel modulation 
in myelinated A-, Ah- and unmyelinated C-type BRNs 
identified by electrophysiological validations. These results 
suggest that NPY and its receptor system play a crucial 
role in sexual dimorphism of BRx afferent function and 
neurocontrol of BP regulation.
Increasing body of evidence has demonstrated that 
NPY receptor expresses in both CNS [22] and PNS [23] 
and is involved in gender-mediated regulation of BP [1] 
and hypertension [7]. Previous researches [24, 25] have 
suggested that NPY is co-stored and co-released with 
norepinephrine (NE) and other catecholamines in adrenal 
medulla or from the postganglionic sympathetic nerves to 
influence the cardiovascular system and correlates with 
sympathetic activation [26]. However, they do not always 
have the synergistic action to influence hemodynamic 
effects. Especially in coronary and cerebral vessels, 
NPY induces significantly vasoconstriction where NE is 
not effective [27, 28]. Our present data demonstrated a 
dramatic sex- and estrogen-related difference in BRS with 
identical serum concentration of NPY among male, age-
Figure 6: Y
1
R and Y2R activation-mediated changes in blood pressure by NG microinjection. The left side of nodose 
ganglion (NG) and Vagus were dissected and exposed carefully on anesthetic rats. The femoral artery cannulation was performed and the 
blood pressure (BP) was collected before and after administration of 5 μg NPY, Pro-34, and NPY13-36, respectively. A. the representatives 
of BP recordings before and after saline (top) and NPY placed on the surface (bottom) of NG; B–D. representative of BP recordings 
before and after NPY, Pro-34, and NPY13-36, respectively, in male (top) and female rats (bottom); The dash line indicates the time of 
the beginning of treatment. E. the summarized changes in the net mean arterial pressure (∆MAP) before and after each treatment in male 
(n = 6) and female (n = 6) rats. The averaged data were expressed by mean ± SD. **P < 0.01 vs. vehicle control, ##P < 0.01 vs. male group.
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matched female, and ovariectomized female rats. This 
observation implied that NPY may influence BRx afferent 
function by the differential expression of its receptor 
subtypes in NG and NTS. The present study indicated 
that the sex-specific lower expression of Y1R in females 
and the upregulation by lacking of estrogen at NG level, 
which may explain at least partially why the BP is lower in 
females vs. age-matched males and significantly increased 
by OVX procedure observed in our previous observation 
[29]. These data are also consistent with the notion that 
Y1R mediates significant sympathetic vasoconstriction 
[30, 31]. Although the Y2R expression is not sex-specific, 
it was upregulated by OVX procedure and downregulated 
by estrogen treatment. Considering that Y1R and Y2R 
often mediate an opposite response of MAP in the present 
study (Figure 6) and work from others [5], the peripheral 
compensatory mechanism may exist to counteract the 
Y1R-mediated vasoconstriction and elevated BP in OVX 
via overexpression of Y2R. Upregulation of Y2R has also 
been confirmed in the rat model of heart failure [32] and 
may be well explained by the evidence of parasympathetic 
vasodilation through presynaptic expression of Y2R.
The sex-difference in Y1R and Y2R expressions has 
been confirmed in the tissue level of NG. However, the 
afferent-specific expression of these receptors needs to 
be clarified to fully understand the cellular mechanism 
of NPY. Due to the multiple afferent neuron types, the 
single-cell RT-PCR [29, 33] would be the best to detect 
mRNA expression in electrophysiologically identified 
individual neurons [13]. The result has demonstrated the 
positive detection for A-, Ah, and C-BRNs are 52.2%, 
36.4%, and 60%, respectively; and the ratios of Y1R/
Y2R for A-, Ah, and C-BRNs are 5/7, 1/7, and 5/10 as 
well. Interestingly, Y2R not only expresses at higher level 
but also distributes predominantly in low-threshold and 
sex-specific subpopulation of Ah-BRNs, suggesting a 
dominant role of Ah-BRNs in sexual-dimorphism of BRx 
afferent function. Even though Y1R equally expresses in 
A- or C-BRNs, its expression level is only about 1/10th 
in Ah-BRNs. In stark contrast, the expression level for 
Figure 7: Effects of Pro34 on AP discharge profiles and ICa in identified A-type BRNs. A–B. action potential (AP) and 
derivative changes before and after 100 nM Pro34; C. repetitive discharge before and after Pro34; Center table: summarized changes in 
AP discharge profiles; D–E. the Ca2+ current (ICa) in identified A-BRNs using slice preparation before and after Pro34; F. current-voltage 
relationship (I-V) of ICa before and after Pro34, inset: averaged data of I-V with different treatments, n = 6-7, **P < 0.01 vs. control at 0 mV; 
G. time course of ICa alternations in the presence of Pro34, 300 nM BIBP3226 (Y1R antagonist) + Pro34, and 100 nM pertussis toxin (PTX) 
+ Pro34, respectively, n = 5 complete recordings, *P < 0.05 and **P < 0.01 vs. before. Scale bars in (E) also apply for (D).
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Y2R is more than 15 or 7 folds higher in Ah-BRNs than 
that in A- or C-BRNs. This novel finding for the first time 
demonstrated that the afferent-specific expression profiles 
of Y1R and Y2R and the likely role of Y1R and Y2R in 
the neurocontrol of circulation and BP regulation at the 
cellular and molecular levels of BRx afferent pathway.
From the functional point of view, Y1R or Y2R 
activation-mediated neuroexcitation and underlying 
ion channel mechanism are the further questions to be 
answered. For A-type BRNs, Y1R activation did not alter 
the AP trajectory but significantly decreased the ICa density, 
suggesting that N-type ICa is not involved in the formation 
of AP waveform [34] or the coupling between KCa1.1 [35] 
and N-type Ca2+ channel although both KCa1.1 α- and β4-
subunits were identified [36]. This observation suggests 
that NPY may be not critical for the neuroexcitation of 
A-types but play some role in cell signaling through 
ICa modulation. Whereas, for C-type BRNs, due to the 
significant higher expression of Y2R observed by single-
cell data and large number of its population compared 
with A-BRNs, somewhat important roles in sex-specific 
neuromodulation at BRx afferent pathway would be 
expected.
Since the sex-specific distribution [12], the key role 
in BRx afferent function [19], unique higher expression of 
Y2R from the current observation, and the effect of Y1R or 
Y2R activation on the neuroexcitation of Ah-type BRNs 
would be the key explanation for the sex-dimorphic BRx. 
Figure 8: Effects of NPY13-36 on AP discharge profiles and ICa in identified Ah-type BRNs. A–B. action potential (AP) 
and derivative changes before and after 100 nM NPY13-36; C–E. summarized changes in APD50, DVMAX, and APFF in the presence of 
NPY13-36, n = 6-10, **P < 0.01 vs. control; F. repetitive discharge before and after NPY13-36; G–H. frequency-dependent prolongation 
of APD50 by superimposition of APs pointed by arrows with numbers during repetitive firings before and after NPY13-36; I. averaged data 
for frequency-dependent prolongation, n = 7, *P < 0.05 and **P < 0.01 vs. control; J–K. whole-cell Ca2+ currents (ICa) recorded in Ah-types 
identified by the conduction velocity (CV) using slice preparation before and after NPY13-36; L. current-voltage relationship (I-V curve) 
of ICa before and after NPY13-36, inset: averaged data of I-V with different treatments, n = 5-7, **P < 0.01 vs. control at 0 mV; M. time 
course of ICa alternations in the presence of NPY13-36, 300 nM BIIE0246 (Y2R antagonist) + NPY13-36, and 100 nM pertussis toxin (PTX) 
+ NPY13-36, respectively, n = 5 complete recordings, *P < 0.05 and **P < 0.01 vs. control. Scale bars in (A) also apply for (G-H); scale 
bar in (K) also apply for (J).
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Figure 9: Effects of directly Y
1
R and Y2R stimulation on AP and ICa in identified C-type BRNs. A–B. action potential (AP) 
and derivatives before and after Y1R (100 nM Pro34); C. representative recordings of Ca
2+ currents (ICa) at 0 mV before and after 100 nM 
Pro34; D–E. AP and derivatives before and after Y2R activation (100 nM NPY13-36); F. representative recordings of ICa at 0 mV before and 
after 100 nM NPY13-36. The center of repolarization hump is indicated by (▼).
Figure 10: Protein Expression of Y
1
R and Y2R in Nucleus of Tractus Solitarii. Protein expression was accessed in tissue of 
nucleus of tractus solitarii (NTS) collected from adult male, aged-matched female, ovariectomized (OVX) female rats. A and B. Protein 
bands for Y1R and Y2R, respectively; C and D. Averaged data of relative expression profiles for Y1R and Y2R. The averaged data were 
presented as mean ± SD. n = 4 duplicated tests in which the tissue was collected from 6 rats of each group. *P < 0.05 vs. male, #P < 0.05 
vs. female.
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Therefore, by Y2R activation, the AP repolarization was 
significantly altered with longer APD50, slower DVMAX, 
faster APFF, and lesser total outward K+ currents from 
AP waveform and phase plots, respectively. Interestingly, 
activity- or frequency-dependent AP broadening [11, 
37] was further enhanced in Ah-type BRNs by Y2R 
activation, rather than Y1R stimulation (data not shown), 
strongly suggesting the Y2R activation-mediated KCa1.1 
inactivation [35, 36] indirectly due to N-type Ca2+ channel 
inhibition through the coupling mechanism.
Even though intriguing observations from the 
cardiovascular literature have provided quantitative 
evidence that myelinated and unmyelinated cardiovascular 
afferents evoke not only different frequency-dependent 
reflex responses but also potential and distinctly different 
sensory information processing mechanisms [38, 39]. 
These differences could be explained at least partially 
by the sex- and afferent-specific expression of Y1R and 
Y2R and an opposite action of Y1R and Y2R activation 
in blood pressure regulation. Additionally, the difference 
in peripheral and central mechanism in neurocontrol 
of circulation mediated by NPY has been identified [3, 
5, 20], manifested as a hypotensive and hypertensive 
responses by Y1R and Y2R activation in NTS (central), 
which was a stark contrast compared with by Y1R and Y2R 
activation in NG (peripheral). Even though the central 
hypotensive action of NPY is led by Y1R activation 
[20], the sex-dimorphism in NPY receptor expression is 
not elucidated so far in NTS. Apparently, averaged Y1R 
protein expression is markedly higher in females than 
that in age-matched male rats, which is downregulated by 
OVX, and similar expression pattern for Y2R is detected in 
NTS. This result may contribute, at least in part, to the sex-
difference in BP of animal [19, 29] and human [40] with an 
estrogen-dependent fashion. Moreover, we have a strong 
reason to believe that myelinated Ah-type barosensitive 
neurons housed in NTS [41, 42] to relay and integrative 
the sensory information of BP (Figure 11). The most 
importantly, the sex- and afferent-specific expression of 
Y1R and Y2R from this study would favor the explanation 
for the sex-difference in IbTX-mediated discharge profiles 
in the 1st-order BRNs [11, 36] of BRx pathway.
Figure 11: The schematic diagram regarding the cellular mechanism underlying neuropeptide Y-mediated sex- and 
afferent-specific neurotransmissions of blood pressure regulation. Notes for the superscript: (1). Y1R highly expressed in 
myelinated A-type BRNs; (2). Y2R mainly expressed in myelinated Ah-type BRNs; (3). action potential duration (APD) was not altered 
by N-type Ca2+ channel inhibition but KCa1.1; (4). This action was restored by estrogen treatment; (5). Y1R expression in nucleus tractus 
solitarii (NTS) was opposite to that in nodose ganglia (NG).
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Although Y1R expression in tissue level of NG is 
slightly increased but statistical significance is not established 
between female and OVX model perhaps due to the smaller 
mass of ganglion tissue leading to a relatively large variation 
and supported by the notion that Y1R expression could be 
further downregulation after estrogen treatment. Whereas, in 
case of Y2R, the expression is identical between sexes but the 
OVX-mediated upregulation is restored with the treatment 
of estrogen, implying that OVX led Y2R upregulation 
would be explained as the compensatory mechanism at NG 
level to counteract elevated Y1R expression when lacking 
of estrogen. In addition, immunofluorescence showed that 
the Y1R expression is further downregulated while Y2R 
upregulation in HCN1-positive populations and together 
with the opposite pressor response mediated by Y1R and 
Y2R, the compensatory neuromodulation of NPY through 
its receptors in neurocontrol of circulation and BP regulation 
is sex-dimorphic and estrogen-dependent.
Taken together, we conclude that NPY would be a 
key player in either peripheral or central pathway in the 
regulation of blood pressure, and collaborative expression 
pattern between Y1R and Y2R at either NG or NTS level 
as well as an opposite pressor response of Y1R and 
Y2R would greatly impact on a sexual dimorphism of 
neurocontrol of circulation and BP.
MATERIALS AND METHODS
An expanded methods section is available in the 
online-only data supplement.
Arterial baroreflex sensitivity
Various doses of phenylephrine (PE) and sodium 
nitroprusside (SNP) were injected intravenously to 
measure the sex difference in baroreceptor sensitivity 
(BRS).
Protein expression of Y
1
R and Y2R
Western Blot analysis was performed for testing 
relative expression of Y1R and Y2R.
Immunohistochemical staining
Due to the afferent-specific expression, the antibody 
against for HCN1 was selected in this experiment as the 
fluorescent marker for myelinated afferents [16, 43], 
so, HCN1-positive and HCN-1-negative neurons were 
presumably classified as myelinated and unmyelinated 
afferents.
Nodose ganglion microinjection of NPY and its 
receptor agonists
As described in the literature [44], after recording 
the baseline (before surgery) of blood pressure, the left 
side NG was exposed and 2 μl saline as the vehicle control 
was directly injected into tissue of ganglion using the 
specific designed needle to confirm the functional intact of 
Vagus and the baseline BP. In the following observation, 
NPY, Pro34 (Y1R agonist), and NPY13-36( Y2R agonist) 
were injected, respectively. The net changes in mean 
arterial pressure (MAP) were collected and analyzed by 
using the software of Labchart 7.
Single-cell quantitative RT-PCR
In order to test the target mRNA examination in 
afferent-specific manner, qRT-PCR was carried out with 
identical procedures as previously described [16] in 
single-neurons identified by standard validation [13].
Neuron afferent type identification
Afferent fiber types of isolated neurons were 
classified as myelinated A-, Ah-, and unmyelinated C-types 
according to electrophysiological and pharmacological 
validations [13] as well as morphological parameters 
[14]. The neurons from slice preparation were identified 
by afferent conduction velocity (CV) [45]. The afferent 
modality of baroreceptor of the 1st-order BRNs housed in 
nodose were also identified by the fluorescence [46].
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